Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

479

HTML

3577

Figures (1-1)

151

Tables (1-1)

128

Sum=4335

Jun 7, 2009 (publication date) through Apr 18, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Articles

World J Gastroenterol. Jun 7, 2009; 15(21): 2628-2631
Published online Jun 7, 2009. doi: 10.3748/wjg.15.2628

Figure 1 Flow-chart of the activities performed, and the results achieved during the observational study. BTLact: Breath test with lactu-lose.

Citation: Peralta S, Cottone C, Doveri T, Almasio PL, Craxi A. Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin. World J Gastroenterol 2009; 15(21): 2628-2631
URL: https://www.wjgnet.com/1007-9327/full/v15/i21/2628.htm
DOI: https://dx.doi.org/10.3748/wjg.15.2628